Fig. 2From: Development and validation of an ECM-related prognostic signature to predict the immune landscape of human hepatocellular carcinomaCross-validation and LASSO Regression. When the curve reaches the lowest point, the error of cross-validation is minimized. At this point, the corresponding figure represents the number of significant lncRNAs (A). LASSO regression plot (B)Back to article page